Concepedia

Fangrong Yan

FY

56

Publications

2.4K

Citations

24

H-Index

2013

Active since

Affiliations

China Pharmaceutical University(Current)

The University of Texas MD Anderson Cancer Center

Anhui Medical University

Shanghai Jiao Tong University

Nanjing Drum Tower Hospital

Fangrong Yan is an author at China Pharmaceutical University specializing in medicine, biostatistics, and engineering.

ORCID

Top concepts

Publications per year

2013–2024

56

Publications

56

Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial

Jing Pan, Yue Tan, Guoling Wang et al. · Journal of Clinical Oncology · 2021 · 280 citations

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome

Xiaofan Lu, Liyun Jiang, Liya Zhang et al. · Neoplasia · 2019 · 243 citations · Full text

<i>MOVICS</i> : an R package for multi-omics integration and visualization in cancer subtyping

Xiaofan Lu, Jialin Meng, Yujie Zhou et al. · Bioinformatics · 2020 · 202 citations · Full text

Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical Trials

Fangrong Yan, Sumithra J. Mandrekar, Ying Yuan · Clinical Cancer Research · 2017 · 171 citations · Full text

BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies

Ruitao Lin, Yanhong Zhou, Fangrong Yan et al. · JCO Precision Oncology · 2020 · 134 citations · Full text

Rows per page

1–5 of 56